CompletedNot Applicable

Spinal Metastasis as the First Presentation of Lung Malignancy: Clinical Characteristics and Postoperative Survival

China139 participantsStarted 2018-01-01

Plain-language summary

The aim of this study is to compare the clinical features and postoperative survival outcomes between patients with spinal metastasis as the initial manifestation of malignancy and those with spinal metastasis occurring after an established diagnosis of malignancy.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥ 18 years.
✓. Pathologically or radiologically confirmed diagnosis of lung cancer with spinal metastasis.
✓. Patients with spinal metastasis who underwent surgical intervention.
✓. Adequate medical records and follow-up data available.

Exclusion criteria

✕. Patients with spinal metastasis originating from non-lung primary tumors.
✕. Patients who did not receive surgical treatment for spinal metastasis.
✕. Incomplete clinical data or lost to follow-up.

What they're measuring

Postoperative Overall Survival

Timeframe: From the date of surgery until death or last follow-up, up to 5 years

Trial details

NCT IDNCT07100444

SponsorGuangdong Provincial People's Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-03-30

View on ClinicalTrials.gov More Lung Cancers trials